Inhibikase Therapeutics, INC. (IKT) — 10-K/A Filings
All 10-K/A filings from Inhibikase Therapeutics, INC.. Browse 1 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (1)
-
Inhibikase Therapeutics Files 10-K/A Amendment
— Apr 25, 2025 Risk: low
Inhibikase Therapeutics, Inc. filed an amendment (10-K/A) on April 25, 2025, for their fiscal year ending December 31, 2024. The company, located in Atlanta, GA
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX